Eli Lilly News - Latest Updates & Headlines
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trial
New Delhi, April 18: Eli Lilly and Company announced on Friday positive topline Phase 3 results from ACHIEVE-1, evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control despite diet and exercise alone.
This drug may result in weight loss for 3 years in adults without diabetes
New Delhi, April 13: Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes, according to new research.
Eli Lilly launches Mounjaro in India for anti obesity treatment
New Delhi, March 20: Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity.
Costly therapies to foster Alzheimer's market growth globally: Report
New Delhi, Jan 14: New expensive but disease-modifying treatments are expected to foster Alzheimer's disease market growth globally, according to a report.